Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 22.1
1.94 %
$ 630 M
Market Cap
35.65
P/E
CSTL - COST OF REVENUE
Cost of Revenue CSTL - Castle Biosciences, Inc.
45 M
LAST VALUE
68.61%
2 YEAR CAGR
53.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR